This section is designed to support you with information that you may require for your formulary submissions and business cases or policy reviews. You can download these resources to support your decision making.

Rate this content: 
Average: 4 (1 vote)
UK | January 2024 | 401018

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]